Takeda Pharmaceutical Co (WBO:TKD) Total Stockholders Equity : €42,939 Mil (As of Dec. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Takeda Pharmaceutical Co Total Stockholders Equity?

Takeda Pharmaceutical Co's Total Stockholders Equity for the quarter that ended in Dec. 2023 was €42,939 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Takeda Pharmaceutical Co's Book Value per Share for the quarter that ended in Dec. 2023 was €27.37. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Takeda Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Dec. 2023 was 0.69.

Takeda Pharmaceutical Co Total Stockholders Equity Historical Data

The historical data trend for Takeda Pharmaceutical Co's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Takeda Pharmaceutical Co Total Stockholders Equity Chart

Takeda Pharmaceutical Co Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Total Stockholders Equity

Get a 7-Day Free Trial

41,262.19

39,703.35

39,975.96

43,517.41

44,400.41

Takeda Pharmaceutical Co Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Total Stockholders Equity	Get a 7-Day Free Trial															43,213.37	44,400.41	45,191.12	44,809.90	42,938.53

Takeda Pharmaceutical Co (WBO:TKD) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Takeda Pharmaceutical Co's Book Value per Share for the quarter that ended in Dec. 2023 is

Book Value per Share	=	(Total Stockholders Equity	-	Preferred Stock)	/	Shares Outstanding (EOP)
	=	(42938.527	-	0)	/	1568.91
	=	27.37

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Takeda Pharmaceutical Co's Debt-to-Equity for the quarter that ended in Dec. 2023 is

Debt-to-Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(2358.343	+	27347.129)	/	42938.527
	=	0.69

Takeda Pharmaceutical Co Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Takeda Pharmaceutical Co's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Takeda Pharmaceutical Co (WBO:TKD) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Takeda Pharmaceutical Co Ltd (WBO:TKD) » Definitions » Total Stockholders Equity

Comparable Companies

Traded in Other Exchanges

TAK:USA TKPHF:USA TAK:Mexico 4502:Japan TKD:Germany TAKP34:Brazil

Address

1-1, Nihonbashi-Honcho 2-Chome, Chuo-ku, Tokyo, JPN, 103-8668

Website

https://www.takeda.com

Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4 trillion in fiscal 2022. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the U.S., 20% from Japan, 20% from Europe and Canada.

Takeda Pharmaceutical Co (WBO:TKD) Headlines

No Headlines